Bortezomib, 1 g

Bortezomib carries a recognized safety classification for professional environments, identified as a peptide aldehyde with a molecular formula of C48H69N14O14. Its molecular weight is 905.18 g/mol. This compound belongs to the class of proteasome inhibitors, specifically targeting the 26S proteasome complex. It is supplied as a white crystalline powder with a purity of 99%. Bortezomib is primarily used in cancer treatment, particularly multiple myeloma, due to its ability to selectively inhibit the chymotrypsin-like activity of the 20S proteasome subunit. Additionally, it has been shown to induce apoptosis in tumor cells.

• CAS Number: 179324-69-7